Hirotsu Bio Science
Business Services · Japan · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Tokyo, Tokyo, JapanWebsite
www.hbio.jpRevenue
$14 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Hirotsu Bio Science
HIROTSU Bio Science Inc. specializes in cutting-edge nematode behavior analysis technology for cancer detection, contributing to early cancer diagnosis through its innovative N-NOSE test. This unique cancer screening method utilizes the olfactory capabilities of nematodes to detect trace odor substances in the urine of cancer patients, fulfilling the need for an affordable, simple, and highly accurate initial cancer test. The company aims to protect the health and future of people worldwide by developing groundbreaking diagnostic technologies. With a commitment to scientific integrity, HIROTSU Bio Science continues to challenge the norms in the field of cancer diagnostics.Explore more
Hirotsu Bio Science Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hirotsu Bio Science your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Hirotsu Bio Science
Website visits: Recent activity has been detected on your website
Check if Hirotsu Bio Science has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Hirotsu Bio Science has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Hirotsu Bio Science launches new products
Hirotsu Bio Science, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Hirotsu Bio Science is spiking on competitors!
Click to see if Hirotsu Bio Science had a recent Job posting/layoffs
Earning: See what the market has to say on Hirotsu Bio Science recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Hirotsu Bio Science is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Hirotsu Bio Science is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Hirotsu Bio Science.
Hirotsu Bio Science Tech Stack
A closer look at the technologies used by Hirotsu Bio Science
Hirotsu Bio Science News & Media
Peer-reviewed review on the real-world data of "N-NOSE" published in an international scientific journal “Biomedicines”
“Biomedicines”, published a peer-reviewed review article* on real-world data showing the effectiveness of our cancer screening test “N-NOSE”. TOKYO, CHIYODA-KU, JAPAN, November 20, 2024 /EINPresswire.com/ -- HIROTSU BIO SCIENCE INC. (Head Office: Tokyo; …Sojitz Signs Memorandum of Understanding for Strategic Alliance with HIROTSU Bioscience, WHO Foundation, OurCrowd and Global Health Equity Fund
TOKYOTOKYO--(BUSINESS WIRE)--The Sojitz Corporation ("Sojitz") has signed a memorandum of understanding with HIROTSU Bioscience Inc. ("HIROTSU"), a developer and provider of N-NOSE®, a primary cancer screening test offering early cancer detection, the WHO Foundation (“WHO Foundation”), OurCrowd, a venture capital firm and the Global Health Equity Fund ("GHEF"), a fund that invests in innovative new medical technologies to tackle health inequity to jointly conduct strategic alliances and feasibiHIROTSU BIO SCIENCE INC.: World's First Test for Early-Stage Pancreatic Cancer, "N-NOSE® plus Pancreas", Now Available
TOKYO--(BUSINESS WIRE)--HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu; hereafter referred to as "HIROTSU") is pleased to announce the commercialization of "N-NOSE plus Pancreas," the first next-generation "cancer type specific test" for the "N-NOSE®". "N-NOSE plus Pancreas" is the world's first test that can detect early-stage pancreatic cancer. Through the “N-NOSE plus Pancreas”, HIROTSU aim to achieve early detection of as many cases of pancreatic c
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Hirotsu Bio Science
Sign Up For FreeTo access detailed company insights
HIROTSU Bio Science Inc. specializes in cutting-edge nematode behavior analysis technology for cancer detection, contributing to early cancer diagnosis through its innovative N-NOSE test. This unique cancer screening method utilizes the olfactory capabilities of nematodes to detect trace odor substances in the urine of cancer patients, fulfilling t... Read More
